Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Diagnostic Performance of Computed Tomography-Based Machine Learning Models in the Classification of Adnexal Masses - A Systematic Review [version 1; peer review: 2 approved]

Дата публикации: 02-04-2026 05:00:59

Introduction Accurate characterization of adnexal masses is a key issue and a crucial step toward improving the outcome of managing a patient with a gynecologic oncology issue. Though ultrasound is a dominant tool for this process, it is subjected to operator variability and is less reliable from a diagnostic perspective. Advances in computed tomography-based radiomics and ML hold great promise as objective diagnostic solutions. Methods This systematic review was performed according to the guidelines suggested by PRISMA. The literature research using PubMed, Embase, Scopus, and Web of Science databases included studies that examined CT-based radiomics and ML model performances for classification of adnexal masses and reported diagnostic performance metrics, including AUC, sensitivity, and specificity. Quality assessment of included studies was performed using the QUADAS 2 tool. Results Eleven studies were included in the review. The performance of CT-based ML models was found to be moderate to excellent, with an AUC ranging from 0.72 to 0.99. Hybrid radiomics-DL algorithms were found to have a higher performance compared to other algorithms. The studies were found to have low risk of bias. Conclusion CT-based radiomics and AI models also hold good prominence as adjunctive tools in differentiating between both benign and malignant adnexal masses and in predicting prognosis. PROSPERO registration: The study has been registered in PROSPERO under the registration number CRD420251266988, on 16 December 2025.

Основное содержимое страницы с новостью.

CROSSMARK_Color_horizontal.svg

Kotian S, - P, R V et al. Diagnostic Performance of Computed Tomography-Based Machine Learning Models in the Classification of Adnexal Masses - A Systematic Review [version 1; peer review: 2 approved]. F1000Research 2026, 15:464 (https://doi.org/10.12688/f1000research.178239.1)

Systematic Review

[version 1; peer review: 2 approved]

Suvarna Kotian1Priyanka -

https://orcid.org/0000-0002-9792-6242

1Varsha R

https://orcid.org/0009-0001-7447-5290

1Rajagopal Kadavigere

https://orcid.org/0000-0003-3486-8740

2Saikiran Pendem

https://orcid.org/0000-0001-7933-1192

1Kaushik Nayak1

Suvarna Kotian1Priyanka -

https://orcid.org/0000-0002-9792-6242

1[...] Varsha R

https://orcid.org/0009-0001-7447-5290

1Rajagopal Kadavigere

https://orcid.org/0000-0003-3486-8740

2Saikiran Pendem

https://orcid.org/0000-0001-7933-1192

1Kaushik Nayak1

Author details Author details

1 Department of Medical Imaging Technology, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, India
2 Department of Radiodiagnosis and Imaging, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India

Suvarna Kotian
Roles: Conceptualization, Data Curation, Investigation, Methodology, Writing – Original Draft Preparation

Priyanka -
Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Supervision, Writing – Review & Editing

Varsha R
Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation

Rajagopal Kadavigere
Roles: Conceptualization, Data Curation, Methodology, Supervision, Writing – Review & Editing

Saikiran Pendem
Roles: Conceptualization, Data Curation, Supervision, Writing – Review & Editing

Kaushik Nayak
Roles: Data Curation, Methodology, Supervision, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

Abstract

Introduction

Accurate characterization of adnexal masses is a key issue and a crucial step toward improving the outcome of managing a patient with a gynecologic oncology issue. Though ultrasound is a dominant tool for this process, it is subjected to operator variability and is less reliable from a diagnostic perspective. Advances in computed tomography-based radiomics and ML hold great promise as objective diagnostic solutions.

Methods

This systematic review was performed according to the guidelines suggested by PRISMA. The literature research using PubMed, Embase, Scopus, and Web of Science databases included studies that examined CT-based radiomics and ML model performances for classification of adnexal masses and reported diagnostic performance metrics, including AUC, sensitivity, and specificity. Quality assessment of included studies was performed using the QUADAS 2 tool.

Results

Eleven studies were included in the review. The performance of CT-based ML models was found to be moderate to excellent, with an AUC ranging from 0.72 to 0.99. Hybrid radiomics-DL algorithms were found to have a higher performance compared to other algorithms. The studies were found to have low risk of bias.

Conclusion

CT-based radiomics and AI models also hold good prominence as adjunctive tools in differentiating between both benign and malignant adnexal masses and in predicting prognosis.

PROSPERO registration: The study has been registered in PROSPERO under the registration number CRD420251266988, on 16 December 2025.

Keywords

Computed tomography, adnexal masses, machine learning model

Corresponding author: Priyanka - Competing interests: No competing interests were disclosed.

Grant information: The author(s) declared that no grants were involved in supporting this work.

Copyright:  © 2026 Kotian S et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Kotian S, - P, R V et al. Diagnostic Performance of Computed Tomography-Based Machine Learning Models in the Classification of Adnexal Masses - A Systematic Review [version 1; peer review: 2 approved]. F1000Research 2026, 15:464 (https://doi.org/10.12688/f1000research.178239.1) First published: 02 Apr 2026, 15:464 (https://doi.org/10.12688/f1000research.178239.1) Latest published: 02 Apr 2026, 15:464 (https://doi.org/10.12688/f1000research.178239.1)

Introduction

Adnexal masses refer to tumoral formations that originate from the ovaries, fallopian tubes, or the surrounding structures like para-ovarian cysts and polyps, found in females of all ages but especially in the reproductive ages. Also, the masses can originate from functional or non-functional tumors due to physiological changes and inflammatory conditions of benign and malignant neoplasms.1 The potential malignancy underscores the importance of early, precise, and prompt diagnosis to reduce associated morbidity and mortality.2 “Adnexal masses” are commonly found during imaging studies of the pelvis. In some instances, particularly those that are not as common, a mass might present with acute or intermittent pain. In the general population, the prevalence of “adnexal masses” cannot be known since most of the adnexal masses remain asymptomatic and undiagnosed.1

Currently, the difference between benign and malignant “Adnexal masses” is primarily determined by their imaging characteristics.35 Ultrasound (USG) is often used as an imaging modality for the evaluation and characterization of adnexal masses based on non-invasive properties and accessibility. It has limitations in terms of dependency and resolution of inconsistency, affecting its sensitivity for distinguishing between benign and malignant masses.6 CT is frequently utilized in routine clinical practice for the incidental initial detection of conditions due to its spatial resolution, broad accessibility, and shorter acquisition duration.7 The characterization of adnexal masses has traditionally depended upon these imaging modalities: techniques and subjective assessments. Nevertheless, there are limitations in evaluating the heterogeneity of masses. Thus, it is important to use a precise, objective, non-invasive approach for the categorization of adnexal masses using CT imaging as it offers higher sensitivity compared to USG, performs nearly at par with MRI, and provides the additional advantage of rapid acquisition.8

The algorithms used by artificial intelligence (AI) have the ability to scrutinize complex image information and enable the early identification and characterization of lesions using image recognition and the detection of minute details that may not be observable by the human eye.913 However, CT-based AI models have excellent accuracy and specificity in classifying lesion, which helps in cancer imaging and treatment monitoring.1416

This review aims to enhance the detection, classification, and characterization of adnexal masses, thereby assisting radiologists in providing more accurate diagnosis. These results may help the gynecologists to choose more appropriate and personalized therapeutic approaches that could improve clinical outcomes and reduce disease aggressiveness in patients with adnexal masses.

Methods

Search strategies

This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.17 The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO), and the checklist is available in supplementary file 1. Ethical approval was not required as this study analysed previously published articles for which approvals had already been obtained.

Databases and search strategy

This literature review search was conducted using four databases such as PubMed, Embase, Scopus, and Web of Science which included the following keywords: adnexal masses, ovarian lesions, machine learning models, radiomics and computed tomography. The detailed search strategy and Boolean operator combinations are given in supplementary file 2.

Study selection

This review includes both prospective and retrospective studies of adnexal masses, mainly assessing the diagnostic, staging and prognosis of lesions through computed tomographic imaging and radiomics models. Original research articles that are ethically approved from the respective institutions and from peer-reviewed journals containing enough amount of automatic segmentation using radiomics models were included. Reviews, editorials, conference abstracts, nonhuman studies, case reports, small case series with fewer than 10 participants, and studies concerning predictive modelling were excluded.

Data extraction

Two reviewers independently performed the literature screening. The duplicate articles were removed using Rayyan.18 Full texts of potentially relevant articles were retrieved and reviewed in detail. Discrepancies were resolved through discussion with a third reviewer. We also developed an extraction template to standardize extraction by including information on the studies, their participants, and diagnostic performance measures like AUC, sensitivity, and specificity. Meta-analysis was not performed in this review due to the heterogeneity between the models used in the included studies.

Risk of bias assessment

The quality and risk of bias of the studies were independently evaluated using the quality assessment of diagnostic accuracy studies 2 (QUADAS-2)19 tool. This established framework looks at potential bias and applicability issues in four main areas: patient selection, index test, reference standard, and flow and timing. Each area was rated as having low, high, or unclear risk of bias. This process ensured a clear and organized evaluation of the studies’ validity and clinical importance.

Results

Selections approaches

After duplicate and abstract removal, a total of 1107 original studies were retrieved, and 12 were found to be eligible for full-text screening. Of these, articles are part of the review that fulfilled the inclusion criteria. This process of selection is elaborated in Figure 1.

9ee3c937-dd83-410d-b236-3cc9da86f171_figure1.gif

Figure 1. PRISMA flow chart for the articles included in the review.

Study characteristics

This systematic review combines the results of 11 retrospective studies on CT radiomics, and machine learning published between 2021 and 2025, with a total sample of 4439 patients. The sample size of each study varied from 149 to 1329 patients, and one study included 185 tumors. The studies were mostly carried out in chine (n = 9), with two multicenter studies including patients from the UK, Germany, USA.2023 Most of the studies were single -center studies (n = 6), with five studies including two to three centers, which improved external validity.

Clinical tasks included differentiation of benign and malignant ovarian tumors (n = 4), differentiation of serous borderline and malignant tumors (n = 2), prediction of FIGO stage (n = 1), detection of peritoneal metastases (n = 1), and prediction of overall survival (n = 2). All studies were performed using contrast -enhanced CT scans, mainly in the portal venous phase, with 3D VOI segmentation in most cases.

Machine learning algorithms used were logistic regression, support vector machine, random forest, K-nearest neighbors, XGBoost, LightGBM, and deep learning models like CNN and U-Net networks. Validation methods used were train-test split validation, internal validation, leave-one-out cross-validation, and external multi-cohort validation. The diagnostic performance reported was excellent, with AUC ranging from 0.79 to 0.96, accuracy of up to 87%, specificity of up to 89%, and prognostic C-index of up to 0.73, thereby confirming the stability of CT-based radiomics models for the characterization of ovarian cancer. The detailed study characteristics of articles included in the review are provided in Table 1.

Table 1. Characteristics of the reviewed studies.

Author (s)CountryNo. centersSample sizeGroup (lesion type)AI modelsOutcomeYu et al., 202121China1182 patientsSerous borderline vs serous malignant tumorsRadiomics + SVM classifierBest AUC 0.86 (Venous phase)Li et al., 202222China31329 patientsBenign vs malignant ovarian tumorsRadiomics + ML (KNN, SVM, RF, LR, MLP, XGBoost); best: MLPMixed model AUC 0.96; Accuracy 0.87Jan et al., 202328Taiwan1149 patientsBenign vs Malignant ovarian tumorsRadiomics + Deep learning (3D U-Net features) + ML ensembleAccuracy 82%; Specificity 89%Li et al., 202323China3287 patientsOvarian cystadenoma vs endometriotic cystLASSO + Logistic regression (nomogram)AUC 0.94 (Validation)Li et al., 202325China2470 patientsType I vs Type II epithelial ovarian cancerLR, SVM, RF, KNN, NB, XGBoostCombined model AUC 0.93Linton-Reid et al., 202320UK, Germany, USA3607 patientsOverall survival (HGSOC)U-Net + ML radiomicsC-index up to 0.73Leng et al., 202427China3201 patientsFIGO stage (early vs advanced)LightGBM, LR, SVM, RF, DTCombined model AUC 0.79 (external)Chen et al., 202424China1258 patientsBenign vs borderline vs early malignant tumorsRF, SVM, LR, KNN, DTRF AUC 0.81(test)Yu et al., 202429China1182 patientsEarly-stage serous borderline vs malignant tumorsRadiomics signature + clinicoradiologiocal nomogramNomogram AUC 0.91 (validation)Su et al., 202530China2455 patientsOverall survival predictionLASSO + Cox ML model5-yr AUC ≈ 0.87Liu et al., 202526China1296 patientsPeritoneal metastasis (PM)Radiomics + Deep learning (CNN)DLRN AUC 0.96

Performance accuracy

Among the studies, radiomics and deep learning models showed moderate to excellent diagnostic performance, with AUC values ranging from 0.72 to 0.99 (Table 2). The highest accuracy was reported by Chen et al.,24 achieving an AUC of 0.98 to 0.99. This was followed by Li et al.25 with an AUC of 0.96, and Liu et al.26 with an AUC of 0.951. Liu et al. integrated radiomics with a ResNet-18 deep learning framework. Most studies reported AUC values above 0.85, indicating strong discriminative ability. Sensitivity ranged from 68% to 91.7%. The highest sensitivity was observed in Liu et al.26 at 91.7% and in Li et al.23 at 90%, indicating good detection performance. Specificity varied from 75% to 99%, with Leng et al.27 achieving the highest specificity at 99%. Overall, models that included wavelet-transformed features, higher-order texture metrics, and deep learning architectures consistently achieved better accuracy. This highlights the advantages of improved feature extraction and hybrid radiomics-DL strategies. These findings confirm the high diagnostic potential of radiomics and AI-based models for characterizing lesions, although differences in feature selection, modeling methods, and validation protocols led to varying performance across studies.

Table 2. Performance accuracy of the included studies.

Author (s) Features extractedFeatures usedAUCSensitivity (%)Specificity (%)Yu et al., 202121Shape, first-order, GLCM, GLRLM, GLSZM, NGTDM9 radiomics features0.868075Li et al., 202222Shape, first-order, GLCM, GLRLM, GLSZM, GLDM, NGTDM, LoG, waveletSelected raiomics subsets0.968190Jan et al., 202328Histogram, GLCM, wavelet, LoG + CNNReduced the combined feature set0.826889Li et al., 202323Shape, first-order, GLCM, GLRLM, GLSZM, GLDM, NGTDM, wavelet, LoG17 Radiomics Features0.9259087.7Li et al., 202325Shape, first-order, texture, wavelet, LoGRadiomics Signature0.87975.680.4Linton-Reid et al., 202320Shape, first-order, texture, waveletOptimal reduced radiomics set0.72NRNRLeng et al., 202427Shape, first-order, GLCM, GLRLM, GLSZM, GLDM, NGTDM, wavelet 7 radiomics features0.838499Chen et al., 202424Shape, first-order, texture, waveletReduced radiomics set0.98–0.99NRNRYu et al., 202429Shape, first-order, texture9 radiomics features0.9098284Su et al., 202530shape, first-order, GLCM, GLRLM, GLSZM, GLDM, NGTDMRad-score features0.816NRNRLiu et al., 202526Radiomics + CNN (ResNet-18)9 radiomics +10 DL features0.95191.795.1

Risk of bias analysis

The quality of the studies included was assessed using the QUADAS-2. Generally, there was a low risk of bias in the domains of patient selection, index test, and reference standard, which is an indication of high methodological quality showed in Figure 2.

9ee3c937-dd83-410d-b236-3cc9da86f171_figure2.gif

Figure 2. QUADAS-2 analysis.

All the studies included in the review, namely Yu et al.,21 Li et al.,25 Jan et al.,28 Li et al.,23 Linton-Reid et al.,20 Leng et al.,27 Chen et al.,24 Yu et al.,29 Su et al.,30 and Liu et al.,26 had a low risk of bias in the domain of patient selection, which is an indication that the studies had appropriate study populations and that there was no selection bias. The domains of index test and reference standard also had low risks of bias, which is an indication that the studies applied the tests appropriately and that they used accepted diagnostic reference standards. Low risk was found in most studies in the flow and timing domain, reflecting appropriate intervals between the index test and reference standard. However, a moderate risk was found in this domain by Leng et al.,27 which could be attributed to differences in follow-up or reporting.

However, concerns regarding applicability were found to be high in most studies, primarily because of the single-center study nature, lack of heterogeneity in the population, and differences in imaging protocols and model validation approaches. Only Li et al.23 and Leng et al.27 reported a moderate level of concerns regarding applicability. Thus, although the internal validity was excellent, external validity is poor, and there is a need for multicenter, externally validated studies.

Discussion

This systematic review draws attention to the increasing importance of CT radiomics and machine learning models in the evaluation of adnexal masses, especially in differentiating benign from malignant ovarian tumors. In general, most of the models used in the studies had moderate to excellent performance, which indicates that image analysis can provide important information beyond visual inspection.

The vast majority of the included studies used contrast-enhanced CT scans, and there was a strong preference for the portal venous phase, as reported by Yu et al.21 and Li et al.31 The portal venous phase offers more stable lesion enhancement and the ability to visualize tumor heterogeneity, which is essential for radiomics analysis. The studies using this phase reported significantly higher AUC values, as reported in the earlier imaging literature that suggests portal venous CT as the optimal phase for ovarian tumor assessment.

With respect to analytical methods, ensemble or hybrid methods tended to perform better than single algorithm classifiers. Li et al.,25 reported that the use of multiple classifiers in ML (random forest, support vector machine, and multi-layer perceptron) resulted in an AUC of 0.96, which was superior to the performance of individual classifiers. Likewise, Li et al.23 showed that the use of nomogram-based methods, which integrated radiomics and logistic regression, was superior in terms of robustness, with a balance between high accuracy and interpretability. By contrast, single-method classifiers like the radiomics-SVM model used by Yu et al.21 tended to perform relatively poorly (AUC 0.86), suggesting a lack of ability to model the complexity of tumors.

The models that integrated deep learning (DL) performed very well in more complex clinical tasks. Liu et al.26 combined the radiomics approach with a ResNet-18 architecture to predict peritoneal metastasis with an AUC of 0.95 and high sensitivity and specificity. Jan et al.28 also combined the 3D U-Net-derived features, showing that the DL approach can extract spatial and hierarchical tumor information that may not be captured by handcrafted radiomics alone. These results are in line with Park et al.,32 who found that the combination of CT texture analysis with ML improved the detection of ovarian malignancy compared to radiologist assessment alone.

When contrasted with previous radiomics analysis reviews in the context of ovarian cancer imaging, the results of this review are consistent with the general consensus that tree-based and boosting methods (random forest, XGBoost, LightGBM) generally perform better than simpler distance-based approaches like K-nearest neighbors and naive Bayes. Previous studies that are not included in this review have also highlighted that hybrid clinicoradiomic models generally offer improved diagnostic performance compared to radiomics models alone.

However, some limitations were apparent despite the encouraging results. The majority of the studies were retrospective and single-center, which may pose a risk of selection bias and lack of generalizability. There was heterogeneity in the parameters of CT image acquisition, segmentation approaches (2D vs. 3D), feature selection algorithms, and validation procedures, making it difficult to compare the results and perform meta-analysis. Moreover, some of the models were not externally validated prospectively, which is essential for clinical use.

Future studies should focus on large-scale, prospective, multi-institutional studies with standardized CT acquisition and radiomics pipelines. The use of fully automated segmentation and end-to-end deep learning models may improve clinical applicability. External validation on different populations and scanner platforms is necessary before clinical application. The combination of radiomics analysis with clinical and genomic information may also help in individualized risk assessment and management of adnexal masses.

Conclusion

CT radiomics and machine learning algorithms have shown great potential as ancillary tools for the assessment of adnexal masses. The algorithms have shown high accuracy and could potentially help radiologists in distinguishing between benign and malignant masses, thus helping in appropriate management. However, before their widespread use, there is a need for further prospective studies. Once validated, these tools could help in improving the accuracy of diagnosis and thus help in personalized management in gynaecologic oncology.

Ethics and consent

This is a review article. Ethical approval and consent were not required.

Data availability

Underlying data

No data is associated with this article.

Acknowledgements

There are no acknowledgments to be made by the authors.

References

  • 1.  Carvalho JP, Moretti-Marques R, Filho AL d S: Adnexal mass: diagnosis and management. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics. 2020; 42(07): 438–443.
  • 2.  Bhagde AD, Jani SK, Patel MS, et al.: An analytical study of 50 women presenting with an adnexal mass. Int. J. Reprod. Contracept. Obstet. Gynecol. 2016; 6(1): 262. Publisher Full Text
  • 3.  Li B, Wang F, Chen L, et al.: Global epidemiological characteristics of uterine fibroids. Arch. Med. Sci. 2023; 19(6): 1802–1810. PubMed Abstract | Publisher Full Text | Free Full Text
  • 4.  Iyer VR, Lee SI: MRI, CT, and PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization. Am. J. Roentgenol. 2010; 194(2): 311–321. PubMed Abstract | Publisher Full Text
  • 5.  Varsha R, Priyanka, Guruvare S, et al.: Diagnostic accuracy of intravoxel incoherent motion and diffusion kurtosis imaging in evaluating endometrial lesions - A systematic review. Radiography. 2025; 31: 103125.
  • 6.  Twickler DM, Moschos E: Ultrasound and Assessment of Ovarian Cancer Risk. Am. J. Roentgenol. 2010; 194(2): 322–329. Publisher Full Text
  • 7.  Sadowski EA, Rockall A, Thomassin-Naggara I, et al.: Adnexal Lesion Imaging: Past, Present, and Future. Radiology. 2023; 307(5): e223281. PubMed Abstract | Publisher Full Text
  • 8.  Kurtz AB, Tsimikas JV, Tempany CMC, et al.: Diagnosis and Staging of Ovarian Cancer: Comparative Values of Doppler and Conventional US, CT, and MR Imaging Correlated with Surgery and Histopathologic Analysis—Report of the Radiology Diagnostic Oncology Group. Radiology. 1999; 212(1): 19–27. PubMed Abstract | Publisher Full Text
  • 9.  Sahu SA, Shrivastava D: A Comprehensive Review of Screening Methods for Ovarian Masses: Towards Earlier Detection. Cureus. 2023; 15(11): e48534. PubMed Abstract | Publisher Full Text
  • 10.  Saroh S, Pendem S, Prakashini K, et al.: Machine learning based radiomics approach for outcome prediction of meningioma – a systematic review. F1000Res. 2025; 14: 330.
  • 11.  Muhaimil A, Pendem S, Sampathilla N, et al.: Role of Artificial intelligence model in prediction of low back pain using T2 weighted MRI of Lumbar spine. F1000Res. 2024; 13: 1035. Publisher Full Text
  • 12.  Zachariah RM, Priya PS, Pendem S: Classification of low- and high-grade gliomas using radiomic analysis of multiple sequences of MRI brain. J. Cancer Res. Ther. 2023; 19(2): 435–446. PubMed Abstract | Publisher Full Text
  • 13.  Nayak SS, Pendem S, Menon GR, et al.: Quality Assessment of MRI-Radiomics-Based Machine Learning Methods in Classification of Brain Tumors: Systematic Review. Diagnostics. 2024 [cited 2026 Feb 12]; 14(23): 2741.
  • 14.  Park H, Qin L, Guerra P, et al.: Decoding incidental ovarian lesions: use of texture analysis and machine learning for characterization and detection of malignancy. Abdom. Radiol. 2021; 46(6): 2376–2383. PubMed Abstract | Publisher Full Text
  • 15.  Gupta S, Nayak K, Pendem S: Impact of slice thickness on reproducibility of CT radiomic features of lung tumors. F1000Res. 2023; 12: 1319. Publisher Full Text
  • 16.  Maiti S, Nayak S, Hebbar KD, et al.: Differentiation of invasive ductal and lobular carcinoma of the breast using MRI radiomic features: a pilot study. F1000Res. 2024; 13: 91. Publisher Full Text
  • 17.  Page MJ, McKenzie JE, Bossuyt PM, et al.: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; n71.
  • 18.  Ouzzani M, Hammady H, Fedorowicz Z, et al.: Rayyan—a web and mobile app for systematic reviews. Syst. Rev. 2016; 5(1): 210. PubMed Abstract | Publisher Full Text | Free Full Text
  • 19.  Yang B, Mallett S, Takwoingi Y, et al.: QUADAS-C: A Tool for Assessing Risk of Bias in Comparative Diagnostic Accuracy Studies. Ann. Intern. Med. 2021; 174(11): 1592–1599. PubMed Abstract | Publisher Full Text
  • 20.  Linton-Reid K, Wengert G, Lu H: End-to-End Integrative Segmentation and Radiomics Prognostic Models Improve Risk Stratification of High-Grade Serous Ovarian Cancer: A Retrospective Multi-Cohort Study.2023.
  • 21.  Yu X, Wang L, Yu H, et al.: MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors. Cancer Manag. Res. 2021; 13: 329–336. PubMed Abstract | Publisher Full Text | Free Full Text
  • 22.  Li J, Zhang T, Ma J, et al.: Machine-learning-based contrast-enhanced computed tomography radiomic analysis for categorization of ovarian tumors. Front. Oncol. 2022; 12.
  • 23.  Li J, Wang F, Ma J, et al.: A CT-based radiomics nomogram for differentiating ovarian cystadenomas and endometriotic cysts. Clin. Radiol. 2023; 78(9): e635–e643. PubMed Abstract | Publisher Full Text
  • 24.  Chen J, Liu L, He Z, et al.: CT-Based Radiomics and Machine Learning for Differentiating Benign, Borderline, and Early-Stage Malignant Ovarian Tumors. Journal of Imaging Informatics in Medicine. 2024; 37(1): 180–195. Publisher Full Text
  • 25.  Li J, Li X, Ma J, et al.: Computed tomography–based radiomics machine learning classifiers to differentiate type I and type II epithelial ovarian cancers. Eur. Radiol. 2022; 33(7): 5193–5204. Publisher Full Text
  • 26.  Liu Y, Yin H, Li J, et al.: CT-Based radiomics and deep learning for the preoperative prediction of peritoneal metastasis in ovarian cancers. Abdom. Radiol. 2025.
  • 27.  Leng Y, Kan A, Wang X, et al.: Contrast-enhanced CT radiomics for preoperative prediction of stage in epithelial ovarian cancer: a multicenter study. BMC Cancer. 2024; 24(1): 307. PubMed Abstract | Publisher Full Text | Free Full Text
  • 28.  Jan Y-T, Tsai P-S, Huang W-H, et al.: Machine learning combined with radiomics and deep learning features extracted from CT images: a novel AI model to distinguish benign from malignant ovarian tumors. Insights Imaging. 2023; 14(1): 68. PubMed Abstract | Publisher Full Text | Free Full Text
  • 29.  Yu X, Zou Y, Wang L, et al.: Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors. Front. Oncol. 2024; 13: 1269589. PubMed Abstract | Publisher Full Text | Free Full Text
  • 30.  Su R, zhang Y, Li X, et al.: CT-based Machine Learning Radiomics Modeling: Survival Prediction and Mechanism Exploration in Ovarian Cancer Patients. Acad. Radiol. 2025; 32(5): 2763–2775. Publisher Full Text
  • 31.  Li J, Zhang T, Ma J, et al.: Machine-learning-based contrast-enhanced computed tomography radiomic analysis for categorization of ovarian tumors. Front. Oncol. 2022; 12: 934735. PubMed Abstract | Publisher Full Text | Free Full Text
  • 32.  Park H, Qin L, Guerra P, et al.: Decoding incidental ovarian lesions: use of texture analysis and machine learning for characterization and detection of malignancy. Abdominal Radiology. 2021; 46(6): 2376–2383. Publisher Full Text
  • 33.  Priyanka: Adnexal masses SR. Dataset. figshare. 2026. Publisher Full Text

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 02 Apr 2026

Comment

Grant information

The author(s) declared that no grants were involved in supporting this work.

Copyright

© 2026 Kotian S et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Open Peer Review

Current Reviewer Status: ?

Key to Reviewer Statuses VIEW HIDE

ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Version 1

VERSION 1

PUBLISHED 02 Apr 2026

Reviewer Report 10 Jun 2026

Priyanka Chandrasekhar, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, Tamil Nadu, India;  Imaging Technology, The Apollo University, Chittoor, Andhra Pradesh, India 

Approved

VIEWS 0

  • Are the rationale for, and objectives of, the Systematic Review clearly stated?

    Yes

  • Are sufficient details of the methods and analysis provided to allow replication by others?

    Yes

  • Is the statistical analysis and its interpretation appropriate?

    Yes

  • Are the conclusions drawn adequately supported by the results presented in the review?

    Yes

  • If this is a Living Systematic Review, is the ‘living’ method appropriate and is the search schedule clearly defined and justified? (‘Living Systematic Review’ or a variation of this term should be included in the title.)

    Not applicable

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Radiology and Imaging Sciences

Close

Reviewer Report 14 May 2026

Manna Debnath, Charotar University of Science and Technology, Anand, Gujarat, India;  Radiography & Advance Imaging Technology, RSMAS, Royal Global University (Ringgold ID: 305831), Guwahati, Assam, India 

Approved

VIEWS 0

  • Are the rationale for, and objectives of, the Systematic Review clearly stated?

    Yes

  • Are sufficient details of the methods and analysis provided to allow replication by others?

    Yes

  • Is the statistical analysis and its interpretation appropriate?

    Yes

  • Are the conclusions drawn adequately supported by the results presented in the review?

    Yes

  • If this is a Living Systematic Review, is the ‘living’ method appropriate and is the search schedule clearly defined and justified? (‘Living Systematic Review’ or a variation of this term should be included in the title.)

    Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Medical Imaging Technology, CT & MRI

Close

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 02 Apr 2026

Comment

Open Peer Review

Reviewer Status

Alongside their report, reviewers assign a status to the article:

Approved
The paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations
A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved
Fundamental flaws in the paper seriously undermine the findings and conclusions

Reviewer Reports

Invited Reviewers
1 2
Version 1
02 Apr 26
read read

  1. Manna Debnath, Charotar University of Science and Technology, Anand, India; Royal Global University (Ringgold ID: 305831), Guwahati, India

  2. Priyanka Chandrasekhar, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, India; The Apollo University, Chittoor, India


Comments on this article


Sign up for content alerts


Browse by related subjects

Alongside their report, reviewers assign a status to the article:

Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Diagnostic Accuracy of PET Imaging for Lymph Node Detection in Breast cancer patients undergoing Upfront Surgery: A Single-Institution Analysis of Breast Cancer Patients [version 3; peer review: 2 approved]0718-06-2026
2Artificial Intelligence Integrated with Intraoral Digital Imaging in Dental Caries Detection, Treatment Planning, and Clinical Decision-Making: A Scoping Review [version 2; peer review: 2 approved, 1 approved with reservations]0805-03-2026
3Web-based Machine Learning Model for Predicting Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus: A Multicenter Study [version 2; peer review: 2 approved]0710-06-2026
4Malware Detection Using RNA Encoding and Convolutional Neural Networks on the Malicious Network Dataset [version 3; peer review: 2 approved]0703-06-2026
5Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors0725-06-2026
6Bioinformatics-based Investigation to Unveiling The miRNA-Immunity Axis in The Tumor Microenvironment of Pancreatic Cancer [version 3; peer review: 2 approved, 1 approved with reservations, 1 not approved]0722-05-2026
7Cone-Beam CT Assessment of the Canalis Sinuosus in an Indian Population: A Retrospective Imaging Study [version 3; peer review: 1 approved, 2 approved with reservations]0825-05-2026
8В МИРЭА научили ИИ находить первичный рак печени с точностью 100%5706-07-2026
9Second Primary Malignant Neoplasms After T-Cell–Engaging Bispecific Antibody Therapy0718-06-2026
10Estos son todos los controles ginecológicos que no deben posponerse0506-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8. Источник: f1000research.com.